Company research
MASIMO CORP
CIK 937556Updated Sep 27, 2026
Securities
Historical securities (1)
MASI · NASDAQ · equity · closed Jun 9, 2026MASI price & chart
Historical security
This listing closed Jun 9, 2026. Live provider charts are shown only for current listings.
About the company
Masimo (Nasdaq: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is to improve life, improve patient outcomes, reduce the cost of care, and take noninvasive monitoring to new sites and applications. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown to outperform other pulse oximetry technologies in over 100 independent and objective studies, which can be found at www.masimo.com/evidence/featured-studies/feature. Masimo SET® is estimated to be used on more than 200 million patients around the world each year and is the primary pulse oximetry at all 10 top U.S. hospitals as ranked in the 2025 Newsweek World’s Best Hospitals listing. Additional information about Masimo and its products may be found at www.masimo.com.
In the news
HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS News provided by Halper Sadeh LLP Dec 05, 2025, 15:20 ET Share this article Share to X Share this article Share to X Shareholders should contact the firm immediately as there may be limited time t ↗
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,698,900,000Source | 2,625,700,000Source | 3,041,500,000Source | 3,210,600,000Source |
| Property, Plant and Equipment, NetUSD | 355,100,000Source | 381,600,000Source | 424,400,000Source | 402,500,000Source |
| GoodwillUSD | 101,000,000Source | 96,700,000Source | 407,700,000Source | 445,400,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | 558,200,000Source | 652,300,000Source | 722,600,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 152,300,000Source | 177,600,000Source | 163,000,000Source | 202,900,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 275,800,000Source | — | 355,500,000Source | 445,900,000Source |
| Inventory, NetUSD | 380,300,000Source | 459,200,000Source | 545,000,000Source | 501,000,000Source |
| Assets, CurrentUSD | 926,000,000Source | 1,225,800,000Source | 1,231,900,000Source | 1,308,600,000Source |
| Operating Lease, Right-of-Use AssetUSD | 32,600,000Source | 74,400,000Source | 59,100,000Source | 69,600,000Source |
| Other Assets, NoncurrentUSD | 44,700,000Source | 100,100,000Source | 89,300,000Source | 114,000,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 977,700,000Source | 1,573,800,000Source | 1,676,700,000Source | 1,871,700,000Source |
| Stockholders’ equity: | ||||
| Additional Paid in CapitalUSD | 929,100,000Source | 838,300,000Source | 783,400,000Source | 782,200,000Source |
| Retained Earnings (Accumulated Deficit)USD | 1,339,400,000Source | 1,490,900,000Source | 1,795,800,000Source | 1,714,300,000Source |
| Stockholders' Equity Attributable to ParentUSD | 721,200,000Source | 1,051,900,000Source | 1,364,800,000Source | 1,338,900,000Source |
| Liabilities and EquityUSD | 1,698,900,000Source | 2,625,700,000Source | 3,041,500,000Source | 3,210,600,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 371,600,000Source | 617,700,000Source | 563,800,000Source | 630,000,000Source |
| Operating Lease, Liability, CurrentUSD | 8,100,000Source | 21,400,000Source | 18,200,000Source | 18,700,000Source |
| Accounts Payable, CurrentUSD | 103,000,000Source | 252,800,000Source | 251,500,000Source | 276,800,000Source |
| Operating Lease, Liability, NoncurrentUSD | 26,900,000Source | 59,500,000Source | 45,800,000Source | 53,400,000Source |
| Deferred Income Tax Liabilities, NetUSD | 200,000Source | 100,100,000Source | 111,700,000Source | 163,600,000Source |
| Other Liabilities, NoncurrentUSD | 87,800,000Source | 128,100,000Source | 129,500,000Source | 136,500,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 9,100,000Source | 31,000,000Source | 26,300,000Source | 39,900,000Source |
| Deferred Revenue, CurrentUSD | 73,200,000Source | 95,500,000Source | 87,300,000Source | 80,600,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | 4,600,000Source | 61,200,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 6,300,000Source | 37,300,000Source | 34,300,000Source | 15,100,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 518,000,000Source | 727,900,000Source | 871,700,000Source | 941,600,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | 143,500,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 38,800,000Source | 103,000,000Source | 98,300,000Source | 136,100,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 35,800,000Source | 41,500,000Source | 7,000,000Source | 47,700,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -2,200,000Source | 65,000,000Source | -90,200,000Source | 138,500,000Source |
| Increase (Decrease) in InventoriesUSD | 112,100,000Source | 7,500,000Source | 69,200,000Source | 155,900,000Source |
| Increase (Decrease) in Accounts PayableUSD | -27,100,000Source | 14,800,000Source | -19,600,000Source | 60,500,000Source |
| Deferred Income Tax Expense (Benefit)USD | 11,800,000Source | -38,200,000Source | -35,600,000Source | -39,300,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 217,800,000Source | 196,400,000Source | 94,100,000Source | 29,400,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | 0Source | -7,500,000Source | 999,700,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 275,100,000Source | -51,200,000Source | -81,200,000Source | -1,057,700,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | 1,700,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 19,400,000Source | 20,000,000Source | 44,000,000Source | 52,800,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 18,000,000Source | 11,800,000Source | 12,900,000Source | 25,400,000Source |
| Payments for Repurchase of Common StockUSD | 363,700,000Source | 0Source | 0Source | 401,500,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -520,700,000Source | -125,600,000Source | -57,100,000Source | 520,400,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -28,100,000Source | 13,200,000Source | -41,400,000Source | -538,800,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 153,300,000Source | 181,400,000Source | 168,200,000Source | 209,600,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | 39,100,000Source | 51,000,000Source | 23,000,000Source |
| Income Taxes Paid, NetUSD | 28,500,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -300,000Source | -6,400,000Source | 2,800,000Source | -30,900,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 35,800,000Source | 41,500,000Source | 7,000,000Source | 47,700,000Source |
| Amortization of Debt Issuance CostsUSD | 3,000,000Source | 1,900,000Source | 1,900,000Source | 1,400,000Source |
| DepreciationUSD | — | 41,300,000Source | 43,900,000Source | 43,000,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -7,600,000Source | 200,000Source | -1,100,000Source | 7,300,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -7,000,000Source | -98,700,000Source | -800,000Source | -500,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | -2,800,000Source | -500,000Source | -17,800,000Source | 0Source |
| GoodwillUSD | 101,000,000Source | 96,700,000Source | 407,700,000Source | 445,400,000Source |
| Goodwill, Impairment LossUSD | — | 294,000,000Source | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 207,700,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | -359,200,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 64,900,000Source | -400,000Source | 6,600,000Source | 49,900,000Source |
| InterestExpenseNonoperatingUSD | 33,200,000Source | 43,600,000Source | — | — |
| Inventory Write-downUSD | — | 52,300,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -151,500,000Source | -304,900,000Source | 81,500,000Source | — |
| Nonoperating Income (Expense)USD | -37,400,000Source | -38,600,000Source | -48,400,000Source | -16,600,000Source |
| Operating ExpensesUSD | 635,200,000Source | 1,271,100,000Source | 867,000,000Source | 848,800,000Source |
| Proceeds from Stock Options ExercisedUSD | 71,400,000Source | 25,200,000Source | 7,000,000Source | 8,100,000Source |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | — | 41,500,000Source | 7,000,000Source | 47,700,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 1,526,900,000Source | 1,395,200,000Source | 2,048,100,000Source | 2,035,800,000Source |
| Cost of RevenueUSD | 581,700,000Source | 600,900,000Source | 1,044,600,000Source | 977,000,000Source |
| Selling, General and Administrative ExpenseUSD | 506,000,000Source | 548,600,000Source | 664,000,000Source | 657,400,000Source |
| Operating Income (Loss)USD | 310,000,000Source | 63,000,000Source | 136,500,000Source | 210,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 272,600,000Source | 21,800,000Source | 88,100,000Source | 193,400,000Source |
| Income Tax Expense (Benefit)USD | 64,900,000Source | 5,600,000Source | 6,600,000Source | 49,900,000Source |
| Net Income (Loss) Attributable to ParentUSD | -151,500,000Source | -304,900,000Source | 81,500,000Source | — |
| Earnings Per Share, BasicUSD per share | -2.83Source | -5.72Source | 1.54Source | 2.68Source |
| Earnings Per Share, DilutedUSD per share | -2.8Source | -5.6Source | 1.51Source | 2.6Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 53,600,000Source | 53,300,000Source | 52,800,000Source | 53,600,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 54,200,000Source | 54,400,000Source | 54,100,000Source | 55,200,000Source |
| Interest Expense (non-operating)USD | 33,200,000Source | 41,200,000Source | — | — |
| Additional Financial Items | ||||
| Cost, Depreciation and AmortizationUSD | — | — | 98,200,000Source | 136,100,000Source |
| Current Income Tax Expense (Benefit)USD | 53,100,000Source | 28,900,000Source | 42,200,000Source | 89,200,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -7,600,000Source | -4,400,000Source | -1,100,000Source | 7,300,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | -2,800,000Source | -500,000Source | -17,800,000Source | 0Source |
| Gross ProfitUSD | 945,200,000Source | 794,300,000Source | 1,003,500,000Source | 1,058,800,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 207,700,000Source | 16,200,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 133,900,000Source | -17,800,000Source | 9,100,000Source | 77,600,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | 3.88Source | 0.3Source | — | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | 3.83Source | 0.3Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | -359,200,000Source | -321,100,000Source | — | — |
| Interest ExpenseUSD | — | — | 50,300,000Source | 25,700,000Source |
| Interest Income, OtherUSD | 3,400,000Source | 4,400,000Source | 3,000,000Source | 1,800,000Source |
| Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost ComponentUSD | — | — | 0Source | — |
| Nonoperating Income (Expense)USD | -37,400,000Source | -41,200,000Source | -48,400,000Source | -16,600,000Source |
| Operating ExpensesUSD | 635,200,000Source | 731,300,000Source | 867,000,000Source | 848,800,000Source |
| Research and Development ExpenseUSD | 126,400,000Source | 182,200,000Source | 175,200,000Source | 191,400,000Source |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | — | 36,100,000Source | 7,000,000Source | 47,700,000Source |
Filing attachments
tm2612557d3_ex99-1.htm · 8-K · 2026-05-04
EX-99.1 2 tm2612557d3_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Masimo Shareholders Approve Acquisition by Danaher IRVINE, Calif. - May 4, 2026 - Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of Merger, dated February 16, 2026 (the “Merger Agreement”), by and among Masimo, Danaher Corporation (“Danaher”) (NYSE: DHR) and Mobiu…
Read attachment ↗tm266533d1_ex99-1.htm · 8-K · 2026-02-17
EX-99.1 4 tm266533d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Masimo to be Acquired by Danaher for $180.00 Per Share IRVINE, Calif. - February 17, 2026 - Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (“Danaher”) will acquire Masimo for $180.00 per share in cash, representing a total consideration of $9.9 billion (the “Transaction”). The Transact…
Read attachment ↗masi-20260112x8kxex991.htm · 8-K · 2026-01-12
EX-99.1 2 masi-20260112x8kxex991.htm EX-99.1 Document Exhibit 99.1 Masimo Announces Select Preliminary 2025 Financial Results Complete fourth quarter and full-year 2025 financial results will be announced on Thursday, February 26, 2026 Irvine, California, January 12, 2026 - Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended January 3, 2026. Preliminary Fourth Quarter 2025 Financial Results: Revenue is expe…
Read attachment ↗masi-20251203xex991.htm · 8-K · 2025-12-03
EX-99.1 2 masi-20251203xex991.htm EX-99.1 Document Exhibit 99.1 Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth Announces Long-Range Targets Including 7% - 10% Revenue CAGR Through 2028 Highlights Clear Focus on Patient Outcomes, Technology Innovation and Commercial Execution Irvine, California, December 3, 2025 - Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an upda…
Read attachment ↗masi-20251104xex991.htm · 8-K · 2025-11-04
EX-99.1 2 masi-20251104xex991.htm EX-99.1 Document Exhibit 99.1 Masimo Reports Third Quarter 2025 Results Irvine, California, November 4, 2025 - Masimo Corporation (Nasdaq: MASI) today announced its financial results for the third quarter ended September 27, 2025. Third Quarter 2025 Results From Continuing Operations(1): GAAP revenue of $371.5 million, representing 8.2% growth on a reported basis; Non-GAAP revenue of $371.2 million, representing 7.6% growth on a constant currency ba…
Read attachment ↗masi-20250929xex991.htm · 8-K · 2025-09-29
EX-99.1 2 masi-20250929xex991.htm EX-99.1 Document Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS On May 6, 2025, Masimo Corporation (the “Company” or “Masimo”) entered into a definitive Stock Purchase Agreement (the “Agreement”) with Harman International Industries, Incorporated, a Delaware corporation (“Buyer”), pursuant to which the Company agreed to sell and transfer to Buyer all of the Company’s equity interests in Viper Holdings Corporation, a Delaware …
Read attachment ↗